- Home
- HKIT vs ATNM Comparison
HKIT vs ATNM Comparison
Compare HKIT & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HKIT
- ATNM
- Stock Information
- Founded
- HKIT 1996
- ATNM 2000
- Country
- HKIT China
- ATNM United States
- Employees
- HKIT N/A
- ATNM N/A
- Industry
- HKIT Computer Software: Prepackaged Software
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- HKIT Technology
- ATNM Health Care
- Exchange
- HKIT Nasdaq
- ATNM Nasdaq
- Market Cap
- HKIT 54.8M
- ATNM 50.2M
- IPO Year
- HKIT 2023
- ATNM N/A
- Fundamental
- Price
- HKIT $1.89
- ATNM $1.47
- Analyst Decision
- HKIT
- ATNM Strong Buy
- Analyst Count
- HKIT 0
- ATNM 2
- Target Price
- HKIT N/A
- ATNM $4.50
- AVG Volume (30 Days)
- HKIT 15.6K
- ATNM 163.5K
- Earning Date
- HKIT 10-31-2025
- ATNM 11-13-2025
- Dividend Yield
- HKIT N/A
- ATNM N/A
- EPS Growth
- HKIT N/A
- ATNM N/A
- EPS
- HKIT N/A
- ATNM N/A
- Revenue
- HKIT $2,904,950.00
- ATNM N/A
- Revenue This Year
- HKIT N/A
- ATNM N/A
- Revenue Next Year
- HKIT N/A
- ATNM N/A
- P/E Ratio
- HKIT N/A
- ATNM N/A
- Revenue Growth
- HKIT N/A
- ATNM N/A
- 52 Week Low
- HKIT $1.15
- ATNM $1.03
- 52 Week High
- HKIT $2.08
- ATNM $2.41
- Technical
- Relative Strength Index (RSI)
- HKIT 60.04
- ATNM 39.85
- Support Level
- HKIT $1.80
- ATNM $1.47
- Resistance Level
- HKIT $2.05
- ATNM $1.59
- Average True Range (ATR)
- HKIT 0.08
- ATNM 0.07
- MACD
- HKIT -0.01
- ATNM -0.01
- Stochastic Oscillator
- HKIT 44.83
- ATNM 10.53
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.